Good morning :)
Place Order
Add to Watchlist

Panchsheel Organics Ltd

PANCHSHEEL

Panchsheel Organics Ltd

PANCHSHEEL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹279 cr, stock is ranked 2,254
High RiskStock is 3.25x as volatile as Nifty
212.400.00% (+0.00)
212.400.00% (+0.00)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹279 cr, stock is ranked 2,254
High RiskStock is 3.25x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹279 cr, stock is ranked 2,254
High RiskStock is 3.25x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
19.612.240.38%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panchsheel Organics Limited makes pharmaceuticals and medicinal chemical products. It also manufactures and exports active pharmaceutical ingredients (APIs), intermediates and finished formulations (both human and veterinary).

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 17.29%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.02% to 0.03%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 28.48%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue40.7040.1342.4548.5150.6949.6769.12104.36107.68112.91
Raw Materialssubtract28.2725.0627.1832.3531.2231.0742.5166.5869.1090.91
Power & Fuel Costsubtract0.690.740.780.930.840.790.871.221.00
Employee Costsubtract2.733.424.094.454.754.574.925.906.55
Selling & Administrative Expensessubtract2.022.632.132.252.582.101.993.222.91
Operating & Other expensessubtract1.021.561.321.332.562.315.916.246.72
Depreciation/Amortizationsubtract1.261.211.221.161.111.111.251.581.742.05
Interest & Other Itemssubtract0.540.500.540.390.310.430.290.550.270.30
Taxes & Other Itemssubtract1.141.811.521.622.032.293.045.005.285.38
EPS3.023.193.664.025.274.988.3112.9011.3110.83
DPS0.500.500.500.500.001.001.500.800.803.20
Payout ratio0.170.160.140.120.000.200.180.060.070.30
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Panchsheel Organics Ltd19.832.240.38%
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57—

Price Comparison

Compare PANCHSHEEL with any stock or ETF
Compare PANCHSHEEL with any stock or ETF
PANCHSHEEL
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 1.95%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding56.12%0.00%1.14%0.00%42.74%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateNov 28, 2024

Interim
Interim | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Nov 28, 2024

Cash Dividend

Ex DateEx DateSep 23, 2024

Final
Final | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Sep 23, 2024

Cash Dividend

Ex DateEx DateAug 27, 2024

Interim
Interim | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Aug 27, 2024

Cash Dividend

Ex DateEx DateMar 7, 2024

Interim
Interim | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Mar 7, 2024

Cash Dividend

Ex DateEx DateDec 4, 2023

Interim
Interim | Div/Share: ₹0.80

Dividend/Share

₹0.80

Ex DateEx Date

Dec 4, 2023

News & Opinions
Corporate
Board of Panchsheel Organics recommends interim dividend

Panchsheel Organics announced that the Board of Directors of the Company at its meeting held on 14 November 2024, inter alia, have recommended the interim dividend of Rs 0.8 per equity Share (i.e. 8%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Panchsheel Organics standalone net profit rises 2.71% in the September 2024 quarter

Net profit of Panchsheel Organics rose 2.71% to Rs 3.79 crore in the quarter ended September 2024 as against Rs 3.69 crore during the previous quarter ended September 2023. Sales rose 14.64% to Rs 27.18 crore in the quarter ended September 2024 as against Rs 23.71 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales27.1823.71 15 OPM %18.8718.73 - PBDT5.695.34 7 PBT5.134.93 4 NP3.793.69 3 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Panchsheel Organics to hold board meeting

Panchsheel Organics will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Panchsheel Organics to conduct AGM

Panchsheel Organics announced that the 35th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Panchsheel Organics to convene board meeting

Panchsheel Organics will hold a meeting of the Board of Directors of the Company on 7 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Panchsheel Organics fixes record date for interim dividend

Panchsheel Organics has fixed 27 August 2024 as record date for payment of interim dividend. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Panchsheel Organics standalone net profit rises 1.18% in the June 2024 quarter

Net profit of Panchsheel Organics rose 1.18% to Rs 3.43 crore in the quarter ended June 2024 as against Rs 3.39 crore during the previous quarter ended June 2023. Sales rose 5.77% to Rs 26.05 crore in the quarter ended June 2024 as against Rs 24.63 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales26.0524.63 6 OPM %17.0119.81 - PBDT5.114.91 4 PBT4.574.53 1 NP3.433.39 1 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Board of Panchsheel Organics recommends interim dividend

Panchsheel Organics announced that the Board of Directors of the Company at its meeting held on 14 August 2024, inter alia, have recommended the interim dividend of Rs 0.8 per equity Share (i.e. 8%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Panchsheel Organics to discuss results

Panchsheel Organics will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live